Cvs Health Corp Stock Performance
| CVS Stock | USD 78.72 0.82 1.05% |
CVS Health has a performance score of 7 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.46, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CVS Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding CVS Health is expected to be smaller as well. CVS Health Corp currently shows a risk of 1.48%. Please confirm CVS Health Corp skewness, and the relationship between the value at risk and day median price , to decide if CVS Health Corp will be following its price patterns.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CVS Health Corp are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, CVS Health may actually be approaching a critical reversion point that can send shares even higher in December 2025. ...more
Actual Historical Performance (%)
One Day Return (0.01) | Five Day Return 0.077 | Year To Date Return 76.44 | Ten Year Return (15.43) | All Time Return 11.5 K |
Forward Dividend Yield 0.0341 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 2.66 | Dividend Date 2025-11-03 |
1 | California Signs PBM Law As Federal PBM Regulation Lags, the States Step Up | 10/30/2025 |
| CVS Health dividend paid on 3rd of November 2025 | 11/03/2025 |
2 | LLYs GLP-1 Duo Boosts Sales Amid Rising Demand for Obesity Drugs | 11/07/2025 |
3 | 3 Stocks That Have Made Epic Comebacks in 2025 | 11/12/2025 |
4 | Chiron Capital Management LLC Has 1.01 Million Stock Holdings in CVS Health Corporation CVS | 11/17/2025 |
5 | Ontario Teachers Pension Plan Board Buys Shares of 4,119 CVS Health Corporation CVS | 11/18/2025 |
6 | Seizert Capital Partners LLC Has 10.63 Million Position in CVS Health Corporation CVS | 11/19/2025 |
7 | CVS Health Names David Joyner Chair of the Board of Directors | 11/20/2025 |
8 | CVS Health Exploring Current Valuation After Recent Share Price Dip | 11/21/2025 |
9 | Rheumatology Therapeutics Market to Hit a Valuation of US 38.34 Billion by 2033 Astute Analytica | 11/24/2025 |
| Begin Period Cash Flow | 8.5 B | |
| Total Cashflows From Investing Activities | -7.6 B |
CVS Health Relative Risk vs. Return Landscape
If you would invest 7,135 in CVS Health Corp on August 27, 2025 and sell it today you would earn a total of 655.00 from holding CVS Health Corp or generate 9.18% return on investment over 90 days. CVS Health Corp is generating 0.1482% of daily returns assuming volatility of 1.4782% on return distribution over 90 days investment horizon. In other words, 13% of stocks are less volatile than CVS, and above 98% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
CVS Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CVS Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CVS Health Corp, and traders can use it to determine the average amount a CVS Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1002
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | CVS | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.48 actual daily | 13 87% of assets are more volatile |
Expected Return
| 0.15 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average CVS Health is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CVS Health by adding it to a well-diversified portfolio.
CVS Health Fundamentals Growth
CVS Stock prices reflect investors' perceptions of the future prospects and financial health of CVS Health, and CVS Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CVS Stock performance.
| Return On Equity | 0.0058 | ||||
| Return On Asset | 0.025 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 169.57 B | ||||
| Shares Outstanding | 1.27 B | ||||
| Price To Earning | 42.99 X | ||||
| Price To Book | 1.36 X | ||||
| Price To Sales | 0.25 X | ||||
| Revenue | 372.81 B | ||||
| Gross Profit | 52.3 B | ||||
| EBITDA | 13.68 B | ||||
| Net Income | 4.59 B | ||||
| Cash And Equivalents | 8.59 B | ||||
| Cash Per Share | 15.21 X | ||||
| Total Debt | 82.92 B | ||||
| Debt To Equity | 1.00 % | ||||
| Current Ratio | 0.94 X | ||||
| Book Value Per Share | 57.42 X | ||||
| Cash Flow From Operations | 9.11 B | ||||
| Earnings Per Share | 0.38 X | ||||
| Market Capitalization | 98.89 B | ||||
| Total Asset | 253.22 B | ||||
| Retained Earnings | 62.84 B | ||||
| Working Capital | (15.96 B) | ||||
| Current Asset | 30.38 B | ||||
| Current Liabilities | 23.17 B | ||||
About CVS Health Performance
Assessing CVS Health's fundamental ratios provides investors with valuable insights into CVS Health's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the CVS Health is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 20.56 | 19.53 | |
| Return On Tangible Assets | 0.03 | 0.03 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.06 | 0.12 |
Things to note about CVS Health Corp performance evaluation
Checking the ongoing alerts about CVS Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CVS Health Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CVS Health Corp has 82.92 B in debt with debt to equity (D/E) ratio of 1.0, which is OK given its current industry classification. CVS Health Corp has a current ratio of 0.92, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for CVS to invest in growth at high rates of return. | |
| Over 90.0% of CVS Health shares are held by institutions such as insurance companies | |
| On 3rd of November 2025 CVS Health paid $ 0.665 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Rheumatology Therapeutics Market to Hit a Valuation of US 38.34 Billion by 2033 Astute Analytica |
- Analyzing CVS Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CVS Health's stock is overvalued or undervalued compared to its peers.
- Examining CVS Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CVS Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CVS Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CVS Health's stock. These opinions can provide insight into CVS Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for CVS Stock Analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.